Prescription Supplements
Total Trials
1
As Lead Sponsor
0
As Collaborator
Total Enrollment
29
NCT05000294
Atezolizumab Plus Tivozanib in Immunologically Cold Tumor Types
Phase: Phase 1/2
Role: Collaborator
Start: Dec 7, 2021
Completion: Jun 30, 2026
Loading map...